Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.62 CHF | -0.27% | -1.14% | -0.26% |
Apr. 17 | Novartis' Multiple Sclerosis Drug Shows Sustained Efficacy for Up to Six Years | MT |
Apr. 17 | Novartis: positive efficacy data in MS | CF |
Filters
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG